Literature DB >> 21504996

Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis.

Søren Møller1, Lise Hobolth, Christine Winkler, Flemming Bendtsen, Erik Christensen.   

Abstract

BACKGROUND: Patients with advanced cirrhosis often develop a hyperdynamic circulation with central hypovolaemia. The events that initiate the systemic haemodynamic abnormalities and the coupling of these factors to splanchnic haemodynamics are still unclear. Objective On the basis of a large population of patients with cirrhosis to identify splanchnic and clinical characteristics associated with the development of the hyperdynamic circulation and survival.
METHODS: We included 410 patients with cirrhosis. In all patients, a full haemodynamic investigation was performed. The data were analysed using regression analyses, principal components analyses, and Cox proportional hazards analyses.
RESULTS: Multivariate regression analyses showed that higher cardiac output was independently associated with higher hepatic venous pressure gradient (HVPG) and higher hepatic blood flow (HBF) (p<0.00001). Higher heart rate was independently associated with presence of ascites and higher HVPG (p<0.0001). Central blood volume and circulation time were independently associated with higher HBF and lower postsinusoidal resistance, respectively (p<0.0001). Systemic vascular resistance was independently associated with lower HVPG (p<0.0001). The final Cox proportional hazards model showed that decreased survival was independently associated with higher age (p=0.003), lower blood haemoglobin concentration (p=0.0006), higher plasma creatinine (p=0.01), higher plasma alkaline phosphatase (p=0.007), lower right atrial pressure (p=0.004), and higher heart rate (p=0.002).
CONCLUSION: The development of the hyperdynamic circulation and central hypovolaemia are mainly explained by changes in portal pressure and HBF. Together with indicators of liver dysfunction, central hypovolaemia is associated with poorer prognosis.

Entities:  

Mesh:

Year:  2011        PMID: 21504996     DOI: 10.1136/gut.2010.235473

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

Review 1.  Management of rectal varices in portal hypertension.

Authors:  Kawtar Al Khalloufi; Adeyinka O Laiyemo
Journal:  World J Hepatol       Date:  2015-12-28

2.  Updates on Hepato-Renal Syndrome.

Authors:  Kyota Fukazawa; H Thomas Lee
Journal:  J Anesth Clin Res       Date:  2013-09-27

3.  Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores.

Authors:  Kara Rye; Gerri Mortimore; Andrew Austin; Jan Freeman
Journal:  J Clin Exp Hepatol       Date:  2016-05-13

4.  Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.

Authors:  David Sacerdoti; Despina Mania; Houli Jiang; Paola Pesce; Silvia Gaiani; Angelo Gatta; Massimo Bolognesi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-01-10       Impact factor: 3.072

Review 5.  Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

6.  Hemodynamic measurements with an abdominal 4D flow MRI sequence with spiral sampling and compressed sensing in patients with chronic liver disease.

Authors:  Octavia Bane; Steven Peti; Mathilde Wagner; Stefanie Hectors; Hadrien Dyvorne; Michael Markl; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2018-10-14       Impact factor: 4.813

7.  In vivo validation of 4D flow MRI for assessing the hemodynamics of portal hypertension.

Authors:  Alejandro Roldán-Alzate; Alex Frydrychowicz; Eric Niespodzany; Ben R Landgraf; Kevin M Johnson; Oliver Wieben; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2012-11-12       Impact factor: 4.813

Review 8.  Recent advances in our understanding of hepatorenal syndrome.

Authors:  Florence Wong
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

9.  Treatment of posthepatitic cirrhosis by Fuzheng Huayu Tablet for reinforcing qi and resolving stasis.

Authors:  Xin Deng; Jian Liang; Zhen-Wei Liu; Fa-Sheng Wu; Xuan Li
Journal:  Chin J Integr Med       Date:  2013-04-02       Impact factor: 1.978

Review 10.  Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension.

Authors:  Alberto Ferrarese; Alberto Zanetto; Giacomo Germani; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2016-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.